About Press Release

This author has not yet filled in any details.
So far Press Release has created 612 blog entries.

KnipBio Announces Breakthrough Aquafeed Ingredient Development

(Lowell, MA) February 16, 2018. – KnipBio, Inc. announced today it has successfully developed a line of KnipBio Meal™, the company’s premium aquafeed ingredient, that contains bio-astaxanthin, the carotenoid that gives salmon, rainbow trout, and shrimp significant health benefits as [...]

RebelBio Partners With Clustermarket To Support Startups With State-Of-The-Art Resources

THE SHARING ECONOMY – A DRIVING FORCE BEHIND INNOVATION The sharing economy is an ever-present force within society. The well-known players like AirBnB or Uber have identified a use for previously unused resources or even expose entire untapped markets. [...]

By | February 16th, 2018|Bioentrepreneurship, Synthetic Biology News|

Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Genomics and Clinical Researchers Conducting Next-Generation Sequencing

New Product Line Leverages Established DNA Synthesis Platform to Revolutionize Exome and Custom Sequencing February 14, 2018 08:00 AM Eastern Standard Time - SAN FRANCISCO--(BUSINESS WIRE)--Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic [...]

Synlogic Presents Data from Immuno-Oncology Development Program Demonstrating Potent Anti-Tumor Immunity Following Administration of Novel STING Agonist-producing Synthetic Biotic™ Medicine

- Data presented at Keystone Symposium demonstrate rapid tumor rejection in preclinical models -  - Data support advancement of Synthetic Biotic medicines as potential immuno-therapies for cancer - February 13, 2018 08:00 AM Eastern Standard Time CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic [...]

Dyadic International, Inc. Announces Research and Development Collaboration To Produce An Active Ingredient in C1

JUPITER, Fla., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development and production of biologic products [...]

Inovio and The Wistar Institute Receive More Than $4.6 Million in R&D Funding to Advance Vaccines Against Tuberculosis & Malaria

PLYMOUTH MEETING, Pa., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the company is collaborating with The Wistar Institute to advance two novel SynCon® vaccine programs against tuberculosis (TB) and malaria, fully funded by more than $4.6 million in total grants from the Bill [...]

tadalafiltablets findviagra.com http://xanaxonlinebuy.com/